The Positron Emission Tomography (PET) Scanners Market is projected to be valued at US$ 1.3 Billion in 2023 and is rising to US$ 2.1 Billion by 2033. The sales of positron emission tomography (PET) scanners grow at a CAGR of 5.3% during the forecast period.
The rising chronic diseases such as cancer and Alzheimer’s are growing the adoption of positron emission tomography (PET) scanners in the healthcare sector. Healthcare manufacturers develop these scanners with radioactive and other advanced technology to enhance the scanner’s quality. Healthcare providers in hospitals are increasing the demand for positron emission tomography (PET) scanners to detect tumors, infected tissues, and cells.
The demand for positron emission tomography (PET) scanners is growing to detect various ovarian, lung, and cervical cancers. The growing popularity of hybrid imaging systems uplifts the market opportunities during the forecast period. The new market entrance, innovative products, emerging advanced technology, and stringent government regulation, propel the positron emission tomography (PET) scanners market.
The growing awareness and innovation of novel techniques to treat patients’ diseases are growing the market opportunities. Moreover, the development of silicon photomultiplier (SiPM) technology to aid diagnosis is surging the market growth during the forecast period.
Request a Sample of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1333
How are Manufacturers Taking Efforts in the Global Positron Emission Tomography (PET) Scanners Market?
Healthcare manufacturers are developing excellent devices in the global market that are less time-consuming and can track most diseases, such as cancer, at an early stage. The adoption of PET scanners with innovative technology drives the market during the forecast period. The manufacturers innovate scanner devices that can detect results with high diagnostic specificity and sensitivity.
The PET scanners can perform the task quickly and easily with the monitoring systems. It helps to provide information related to metabolism with its imaging techniques. The manufacturers are focused on add-on features and radiotracers to address the diagnosis, staging, and response to the treatment of diseases. Therefore, actively launching their effective products with notable improvement is driving market opportunities.
Key Takeaways:
- The positron emission tomography (PET) scanners market is expected to have a valuation of US$ 2.1 Bn by 2033.
- With a CAGR of 5.3%, the global market is increasing during the forecast period.
- The market in the United States is anticipated to grow at a CAGR of 5.4% through 2033.
- With a CAGR of 4.0%, the U.K. market significantly uplifts during the forecast period.
- The China market is expected to grow at a CAGR of 6.6% over the forecast period.
Inquire Before Buying Research Report: https://www.futuremarketinsights.com/ask-question/rep-gb-1333
Who is Winning?
The number of key players fragments the market present all around the globe during the forecast period. The prominent players are trying to present innovative devices by adopting new technologies in the market. The players are focusing on developing better detection scanners with better resolution of PET imaging.
Apart from this, these players are engaged in research activities and getting approval for their devices to expand the market globally. Various marketing tactics such as mergers, acquisitions, product launches, collaborations and agreements are adopted by key players to expand their market size.
Some of the prominent players in the market are:
- E. Healthcare
- Toshiba Corporation
- Koninklijke Philips N.V.
- Siemens Healthineers
- Hitachi Medical Corporation
- Positron Corporation
- Mediso Ltd.
- Yangzhou Kindsway Biotech Co., Ltd
Recent Development
- In 2020, the report published by Globocon stated that around 19,292,789 cancer cases were estimated, and nearly 9,958,133 deaths were reported all around the globe.
- In Oct 2021, Wipro G.E. Healthcare announced its first PET MR in India at the State Cancer Institute GMC in Guwahati. The company has launched its fourth PET scanner in India, including the digital one named- G.E.’s SIGNA PET/MR 2.0.
- In Mar 2021, Siemens announced the FDA-approved Biograph Vision Quadra Scanner designed for clinical use. It helps scientific research and therapies and improves healthcare procedures.
Buy This Report: https://www.futuremarketinsights.com/checkout/1333
Positron Emission Tomography (PET) Scanners Market by Category
By Product Type:
- Full-ring PET Scanner
- Partial-ring PET Scanner
By Application:
- Oncology
- Cardiology
- Neurology
- Others
By Detector Type:
- Bismuth Germanium Oxide
- Lutetium Oxyorthosilicate
- Gadolinium Oxyorthosilicate
- Lutetium Fine Silicate
- Lutetium Yttrium Orthosilicate
By End User:
- Hospitals
- Diagnostic Centers
- PET Centers
- Research Institute
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs
